Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with 131I‐meta‐iodobenzylguanidine (131I‐mIBG)
- 1 July 2001
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 55 (1), 47-60
- https://doi.org/10.1046/j.1365-2265.2001.01309.x
Abstract
OBJECTIVE Meta‐iodo‐benzyl‐guanidine labelled with 131‐iodine (131I‐mIBG) has been used extensively for imaging tumours originating from the neural crest but experience with its therapeutic use is li...This publication has 27 references indexed in Scilit:
- Management of Gastroenteropancreatic Endocrine Tumors: The Place of Somatostatin AnaloguesDigestion, 1994
- Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidineNuclear Medicine Communications, 1993
- A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumourEuropean Journal Of Cancer, 1992
- Familial phaeochromocytoma: Successful treatment with131I-MIBGMedical and Pediatric Oncology, 1990
- Long‐term Results in 64 Patients Operated Upon for PheochromocytomaActa Medica Scandinavica, 1988
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Malignant PhaeochromocytomaBritish Journal of Urology, 1985
- Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidineNuclear Medicine Communications, 1984
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981